Eslicarbazepine Acetate
Eslicarbazepine Acetate (Zebinix) is an anticonvulsant medication approved for use in Europe, the United States and Canada as an adjunctive therapy for partial-onset seizures that are not adequately controlled with conventional therapy.
| Catalog Number | T3285 |
| Alternative Name(s) | Zebinix , Aptiom , BIA 2-093 , Exalief , Stedesa |
| Research Area | Membrane transporter/Ion channel|||Neuroscience |
| Molecular Formula | C17H16N2O3 |
| CAS# | 236395-14-5 |
| Purity | 100.00% |
| SMILES | c12c(cccc1)N(c1ccccc1C[C@@H]2OC(=O)C)C(=O)N |
| Size | 500 mg |
| Supplier Page | https://www.targetmol.com/compound/Eslicarbazepine Acetate |
| Additional Information | https://www.targetmol.com/datasheet/T3285 |
